Q4 2026
Next results · Q4 2026Projected
Feb 8, after the close
Mon, Feb 8, 2027in 93 days
Projected from its last 8 releases. The company has not named the day yet.
- Quarter
- Q4 2026 · Ends about Dec 31, 2026
- 10-K window
- Feb 26 – Mar 26
Read against Q4 2025
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
- Revenue
- $4.73M
- Revenue, change from a year earlier: Q3 2026 +18.0%, Q2 2026 +36.2%, Q1 2026 +6.9%, Q4 2025 +22.2%
- Net income
- $62.00K
- Net income, change from a year earlier: Q3 2026 +51.9%, Q2 2026 +405.1%, Q1 2026 −74.9%, Q4 2025 −82.2%
- EPS
- —
- EPS, change from a year earlier: Q3 2026 +66.7%, Q2 2026 +450.0%, Q1 2026 −80.0%, Q3 2025 +50.0%
Results day
Typical moveA typical move of 9.8% either way
Up after 6 of 12, down after 6.
The stock’s move from the last close before each release to the first close after it, over the last 12 releases. Largest: +33.1% after Q2 2025.
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
When it reports
- Usual day
- Thursday
- 7 of its last 8
- Session
- after the close
- After quarter end
- 37 to 65 days
- 10-Q filed
- 37 to 45 days
- over its last 8
- 10-K filed
- 60 to 82 days
- over its last 8
Based on 8 prior 10-K filings.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR